Volume 8, Issue 3

• Early Perception of Medication Benefit Predicts Subsequent Antipsychotic Response in Schizophrenia: �??The Consumer Has a Point�?� Revisited
  Author(s): Haya Ascher-Svanum, Peter Weiden, Allen W. Nyhuis, Douglas E. Faries, Virginia Stauffer, Sara Kollack-Walker, Bruce J. Kinon
  • Abstract
  • PDF
• Religion�??s Effect on Mental Health in Schizophrenia: Examining the Roles of Meaning-Making and Seeking Social Support
  Author(s): Naomi T. Tabak, Amy Weisman de Mamani
  • Abstract
  • PDF
• Schizophrenia: A Systemic Disorder
  Author(s): Brian Kirkpatrick, Brian Miller, Clemente García-Rizo, Emilio Fernandez-Egea
  • Abstract
  • PDF
• Paliperidone Palmitate versus Risperidone Long-Acting Injection in Markedly-to-Severely Ill Schizophrenia Subjects: Onset of Efficacy with Recommended Initiation Regimens
  Author(s): Dong-Jing Fu, Cynthia A. Bossie, Jennifer Kern Sliwa, Yi-Wen Ma, Larry Alphs
  • Abstract
  • PDF
• Highlights from the 2014 Schizophrenia International Research Society Conference April 5�??9, 2014
  Author(s): Allison A. Curley
  • Abstract
  • PDF
• Update on putative novel antipsychotics
  Author(s): Peter F. Buckley
  • PDF